DOCSLIB.ORG
  • Sign Up
  • Log In
  • Upload
  • Sign Up
  • Log In
  • Upload
  • Home
  • »  Tags
  • »  Fluocortin

Fluocortin

  • (CD-P-PH/PHO) Report Classification/Justifica

    (CD-P-PH/PHO) Report Classification/Justifica

  • 1532 Corticosteroids

    1532 Corticosteroids

  • Roger M. Katz, M.D. 11500W.Olympicblvd.,Suite630 Phone:(310)393-1550 Losangeles,CA90064 Fax:(310)478-3601

    Roger M. Katz, M.D. 11500W.Olympicblvd.,Suite630 Phone:(310)393-1550 Losangeles,CA90064 Fax:(310)478-3601

  • SUPPLEMENTARY APPENDIX 4: Search Strategies Syntax Guide For

    SUPPLEMENTARY APPENDIX 4: Search Strategies Syntax Guide For

  • Contact Dermatitis to Medications and Skin Products

    Contact Dermatitis to Medications and Skin Products

  • Basic Skin Care and Topical Therapies for Atopic Dermatitis

    Basic Skin Care and Topical Therapies for Atopic Dermatitis

  • (12) United States Patent (10) Patent No.: US 7,544,192 B2 Eaton Et Al

    (12) United States Patent (10) Patent No.: US 7,544,192 B2 Eaton Et Al

  • Wo 2008/127291 A2

    Wo 2008/127291 A2

  • Intranasal Steroids and the Myth of Mucosal Atrophy: a Systematic Review of Original Histological Assessments

    Intranasal Steroids and the Myth of Mucosal Atrophy: a Systematic Review of Original Histological Assessments

  • A Systematic Review of the Safety of Topical Therapies for Atopic Dermatitis J

    A Systematic Review of the Safety of Topical Therapies for Atopic Dermatitis J

  • BDS: CALUX Bioassays

    BDS: CALUX Bioassays

  • United States Patent (10) Patent No.: US 9.447,027 B2 Milan Et Al

    United States Patent (10) Patent No.: US 9.447,027 B2 Milan Et Al

  • WO 2009/023943 Al

    WO 2009/023943 Al

  • Wo2 11/141 2 A2

    Wo2 11/141 2 A2

  • Atopic Dermatitis Pathogenesis

    Atopic Dermatitis Pathogenesis

  • Harmonized Tariff Schedule of the United States (2004) -- Supplement 1 Annotated for Statistical Reporting Purposes

    Harmonized Tariff Schedule of the United States (2004) -- Supplement 1 Annotated for Statistical Reporting Purposes

  • Absence of Nasal Mucosal Atrophy with Fluticasone Aqueous Nasal Spray

    Absence of Nasal Mucosal Atrophy with Fluticasone Aqueous Nasal Spray

  • Poison Or Antibiotic? a Guide to

    Poison Or Antibiotic? a Guide to "Class" Entries

Top View
  • Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
  • Fludrocortisone Acetate/Fluocinolone Acetonide 1531
  • Previous Versions
  • Intranasal Corticosteroids Versus Oral H1 Receptor Antagonists
  • Transdermal Device Containing
  • Alternatives for the 2007 North American Contact Dermatitis Group (NACDG) Standard Screening Tray
  • Study Protocol
  • Customs Tariff - Schedule Xxi - 1
  • All Things Contact Dermatitis™ SEPTEMBER 2017 NEWS & NOTES
  • Contact Dermatitis: a Practice Parametereupdate 2015
  • (12) Patent Application Publication (10) Pub. No.: US 2009/0312724 A1 Pipkin Et Al
  • Comparative Assessment of Safety and Efficacy of Inhaled Corticosteroids: Report of a Committee of the Canadian Thoracic Society
  • United States Patent (19) (11) 4,343,798 Fawzi 45) Aug
  • 210311 Wild Guided Report.Indd
  • JIA Guideline Appendix 4
  • Harmonized Tariff Schedule of the United States (2006) (Rev
  • The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
  • United States Patent (19) 11 Patent Number: 6,126,920 Jones Et Al


© 2024 Docslib.org    Feedback